200 related articles for article (PubMed ID: 37499186)
1. Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis.
Galimzhanov A; Istanbuly S; Tun HN; Ozbay B; Alasnag M; Ky B; Lyon AR; Kayikcioglu M; Tenekecioglu E; Panagioti M; Kontopantelis E; Abdel-Qadir H; Mamas MA
Eur J Prev Cardiol; 2023 Dec; 30(18):2018-2031. PubMed ID: 37499186
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level.
Gue YX; Bisson A; Bodin A; Herbert J; Lip GYH; Fauchier L
Eur J Clin Invest; 2022 Jun; 52(6):e13754. PubMed ID: 35113450
[TBL] [Abstract][Full Text] [Related]
3. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Alon L; Corica B; Raparelli V; Cangemi R; Basili S; Proietti M; Romiti GF
Eur J Prev Cardiol; 2022 May; 29(6):938-946. PubMed ID: 34939092
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
Mehra MR; Vaduganathan M; Fu M; Ferreira JP; Anker SD; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; Spiro TE; Deng H; Zannad F; Greenberg B
Eur Heart J; 2019 Nov; 40(44):3593-3602. PubMed ID: 31461239
[TBL] [Abstract][Full Text] [Related]
7. Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis.
Kaze AD; Zhuo M; Kim SC; Patorno E; Paik JM
Cardiovasc Diabetol; 2022 Mar; 21(1):47. PubMed ID: 35321742
[TBL] [Abstract][Full Text] [Related]
8. HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database.
Alonso A; Barnes AE; Guest JL; Shah A; Shao IY; Marconi V
J Am Heart Assoc; 2019 Jul; 8(14):e012241. PubMed ID: 31266386
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.
Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS
BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855
[TBL] [Abstract][Full Text] [Related]
10. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
11. Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study.
Lee YB; Han K; Kim B; Lee SE; Jun JE; Ahn J; Kim G; Jin SM; Kim JH
Cardiovasc Diabetol; 2019 Nov; 18(1):157. PubMed ID: 31733656
[TBL] [Abstract][Full Text] [Related]
12. Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
van Veldhuisen SL; Gorter TM; van Woerden G; de Boer RA; Rienstra M; Hazebroek EJ; van Veldhuisen DJ
Eur Heart J; 2022 May; 43(20):1955-1969. PubMed ID: 35243488
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of atrial fibrillation in patients with stable coronary artery disease: a systematic review and meta-analysis of adjusted observational studies.
Saglietto A; Varbella V; Ballatore A; Xhakupi H; Ferrari GM; Anselmino M
Rev Cardiovasc Med; 2021 Jun; 22(2):439-444. PubMed ID: 34258910
[TBL] [Abstract][Full Text] [Related]
14. Risk of Adverse Cardiovascular Outcomes in Differentiated Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis.
Qiang JK; Alwithenani R; Uleryk E; Ezzat S; Lipscombe LL; Sawka AM
Thyroid; 2023 Feb; 33(2):192-202. PubMed ID: 36074932
[No Abstract] [Full Text] [Related]
15. Antibiotics for secondary prevention of coronary heart disease.
Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
[TBL] [Abstract][Full Text] [Related]
16. Plasma TSH and cardiovascular disease in the general population: A Mendelian randomization study of 105,224 individuals.
Dalila N; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
Atherosclerosis; 2023 Jul; 376():26-33. PubMed ID: 37263031
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
[TBL] [Abstract][Full Text] [Related]
18. Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years.
Seki H; Kaneko H; Morita H; Itoh H; Morita K; Matsuoka S; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Yano Y; Nakamura S; Node K; Yasunaga H; Komuro I
Am J Cardiol; 2021 Aug; 152():150-157. PubMed ID: 34140140
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor.
Hu WS; Lin CL
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1977-1986. PubMed ID: 36881169
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.
Li CX; Liang S; Gao L; Liu H
PLoS One; 2021; 16(2):e0244689. PubMed ID: 33606705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
